Skip to main content

FDA grants tentative approval for generic version of Zyprexa


ROCKVILLE, Md. The Food and Drug Administration has granted tentative approval to Roxane Labs’ generic version of Eli Lilly and Co.’s antipsychotic drug, Zyprexa, FDA records show.

The FDA passed tentative approval for the generic version of the drug in the 5 mg strength Nov. 20.

Several other drug makers, such as Teva, Mylan, Sandoz and Barr Labs, also are developing generic versions of Zyprexa.

This ad will auto-close in 10 seconds